[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents]

Ann Urol (Paris). 1998;32(1):15-9.
[Article in French]

Abstract

221 clinically significant enterococcal strains (191: E. faecalis, 27: E. faecium, 3 others) were isolated from the urine of patients hospitalised with UTI over an 18-month period (1995-1996). The susceptibility of the isolates to 8 antimicrobial agents was determined by agar dilution method (NCCLS). All enterococci were sensitive to vancomycin and most of them (over 92%) to penicillin and ampicillin. Only 3.14% of E. faecalis and 3.70% of E. faecium were resistant to ciprofloxacin. A relatively high incidence of resistance of enterococci to aminoglycosides was observed: 46.07% and 51.85% to streptomycin, 42.41% and 44.44% to gentamicin, 70.68% and 77.78% to amikacin for E. faecalis and E. faecium, respectively. Among the resistant to penicillin and amino glycosides enterococci of the two species was found a great percent "high level" resistance. There were no beta-lactamase producers among our strains. The established multiresistance accompanied by "high level" resistance requires careful consideration of antimicrobial therapy of enterococcal UTI.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Amikacin / pharmacology
  • Ampicillin / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology
  • Bacteriuria / microbiology
  • Child
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Microbial
  • Enterococcus / classification*
  • Enterococcus / drug effects
  • Enterococcus / enzymology
  • Enterococcus / isolation & purification
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / enzymology
  • Enterococcus faecalis / isolation & purification
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / enzymology
  • Enterococcus faecium / isolation & purification
  • Gentamicins / pharmacology
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Penicillin Resistance
  • Penicillins / pharmacology
  • Streptomycin / pharmacology
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / microbiology*
  • Vancomycin / pharmacology
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Gentamicins
  • Penicillins
  • Ciprofloxacin
  • Vancomycin
  • Ampicillin
  • Amikacin
  • beta-Lactamases
  • Streptomycin